1-3 of 3
Simon TS Durrant
Close
Sort by
Journal Articles

A Phase I Study Of KB004, a Novel Non-Fucosylated humaneered® Antibody, Targeted Against The Receptor Tyrosine Kinase EphA3, In Advanced Hematologic Malignancies

Jeffrey E Lancet, MD, Andrew H Wei, MBBS, PhD, Simon TS Durrant, Mark S. Hertzberg, MBBS, PhD, FRACP, FRCPA, Ronan T. Swords, MD, PhD, FRCPI, FRCPath, Ian D Lewis, MB, BS, PhD, Brian Jonas, MD, PhD, Jorge E. Cortes, MD, Geoffrey Yarranton, PhD, Jackie M. Walling, MBChB, PhD
Journal: Blood
Blood (2013) 122 (21): 3838.
https://doi.org/10.1182/blood.V122.21.3838.3838
Published: 2013
Journal Articles

Prolonged Transportation Time Of Haemopoietic Progenitor Cells Does Not Impact Upon Engraftment Or Overall Survival Following Allogeneic Voluntary Unrelated Donor Transplantation

Cheryl J Hutchins, Jason P Butler, Angela McLean, Judith Y Cummings, Geoff R Hill, James A Morton, Glen A Kennedy, Simon TS Durrant
Journal: Blood
Blood (2013) 122 (21): 694.
https://doi.org/10.1182/blood.V122.21.694.694
Published: 2013
Journal Articles

The Addition Of Interleukin-6 Inhibition To Standard Gvhd Prophylaxis Prevents Acute Gvhd: Interim Results Of a Phase I/II Clinical Study

Glen A Kennedy, Antiopi Varelias, Slavica Vuckovic, Ping Zhang, Kelli PA MacDonald, Justine Leach, Elise Sturgeon, Judy Avery, Stuart D Olver, Mary Lor, Cheryl J Hutchins, James A Morton, Simon TS Durrant, Ashish Misra, Elango Subramoniapillai, Jason P Butler, Cameron Curley, Siok K Tey, Geoffrey R Hill
Journal: Blood
Blood (2013) 122 (21): 908.
https://doi.org/10.1182/blood.V122.21.908.908
Published: 2013